Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Riera J
  • Alcántara S
  • Bonilla C
  • Fortuna P
  • Blandino Ortiz A
  • Vaz A
  • Albacete C
  • Millán P
  • Ricart P
  • Victoria Boado M
  • Ruiz de Gopegui P
  • Santa Teresa P
  • Sandoval E
  • Pérez-Chomón H
  • González-Pérez A
  • Duerto J
  • Colomina J
  • Gómez V
  • Renedo G
  • Naranjo J
  • Alfonso García M
  • Rodríguez-Ruiz E
  • Eduardo Silva P
  • Pérez D
  • Veganzones J
  • Voces R
  • Martínez S
  • Blanco-Schweizer P
  • García M
  • Villanueva-Fernández H
  • Paz Fuset M
  • María Luna S
  • Martínez-Martínez M
  • Argudo E
  • Chiscano L
  • Roncon-Albuquerque R Jr

Grupos

Abstract

Series describing the evolution of patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19 and supported with extracorporeal membrane oxygenation (ECMO) during the first wave of the pandemic have reported mortalities ranging from 30 to 60% [1, 2]. More recent publications have demonstrated a trend towards a higher mortality in COVID-19 patients receiving support in later periods of the pandemic, even though the overall mortality of the disease seems lower [3, 4]. The reasons for this difference are not clear.

Datos de la publicación

ISSN/ISSNe:
0903-1936, 1399-3003

EUROPEAN RESPIRATORY JOURNAL  EUROPEAN RESPIRATORY SOC JOURNALS LTD

Tipo:
Letter
Páginas:
-
Factor de Impacto:
4,336 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 11

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • MEMBRANE-OXYGENATION; DISTRESS-SYNDROME

Campos de estudio

Proyectos asociados

IMPACTO DEL ECMO SOBRE LA FARMACOCINÉTICA DE LA ANIDULAFUNGINA.

Investigador Principal: FRANCISCA PÉREZ ESTEBAN

PFI-ANI-2013-01

Cita

Compartir